Several recent reports support the hypothesis that apoptosis occurring in leukocytes of human immunodeficiency virus type 1 (HIV-1)-infected individuals is important in progression to AIDS. Specifically, apoptosis of uninfected bystander cells appears critical in the pathogenesis of disease. Here, we present evidence that protease-defective, gp120-containing HIV-1 (L-2) particle preparations specifically induce apoptosis in cells obtained from a subset of promonocytic U937-derived subclones. The rate of apoptosis induction was inversely correlated with the susceptibility of the U937 subclones to wild-type HIV-1 infection. Three types of apoptosis experiments were performed: DNA content analysis by flow cytometry, apoptotic nuclear degradation by fluorescent microscopy and DNA fragmentation analysis by agarose gel electrophoresis. Kinetic analysis revealed that there was a slower induction of apoptosis by L-2 particle preparations than with tumor necrosis factor (TNF)-a or anti-Fas antibody. However, there were no significant differences in the initial binding rates of L-2 particles as well as the binding of TNF-a or anti-Fas antibody to the U937 subclones. The basal level of protein kinase C activity was higher in high-type subclones compared with low-type subclones. These results suggest that U937 cells can be divided into at least two subpopulations, one that permits a productive HIV-1 infection but is not subjected to L-2 particle preparation-induced apoptosis, while the other poorly replicates HIV-1 and is subjected to , L-2 mediated apoptosis, although at a slower rate than found with TNF-a or anti-Fas antibody.
Introduction
Human immunodeficiency virus type 1 (HIV-I), the etiological agent of AIDS (1, 2) , induces the gradual depletion of CD4' cells, which in turn regulates the degree of virus-induced pathogenesis. Recent findings have suggested that this depletion results from apoptosis either directly associated with HIV-1 replication (3) (4) (5) or indirectly resulting from the action of several viral proteins (6-1 1). Specifically, apoptosis can be induced in vitro in most AlDS patient's peripheral blood mononuclear cells (PBMC) as an activation-dependent event after stimulation with mitogens, a calcium ionophore, superantigens, recall antigens or anti-CD3 (12-1 7) . This global impairment of CD4' T cell function of PBMC in vitro contrasts progression (18, 19, 25, 26) . The rapid and extensive degree of HIV-1 replication in wVohas been demonstrated by quantifying serial changes in viral genotype and phenotype in the plasma and PBMC resulting from resistance to antiviral drugs (27, 28) . Therefore, HIV-1-mediated apoptosis also appears closely correlated with the level of virus load; however, it has also been shown that 99.99% or more of HIV-1 in plasma are not infectious (25) , suggesting instead that apoptosis in vivo may be related to the presence of defective particles (29) .
In our earlier papers, we established several clones of surviving CD4
+ MT-4 cells after infection with wild-type HIV-1 (LAI) or infectious, molecularly cloned pNL432-derived virus (30) (31) (32) . Most of the cell clones carried defective proviral accessory genes (33) (34) (35) . During the course of these studies, we showed that one of the subclones, L-2, produced proteasedefective, non-infectious particles with a single base insertion in the protease gene leading to the appearance of uncleaved Pr55 ga9 (36) . Also, L-2 particles contained cleaved env gene products, gp120 and gp41, but were defective in reverse transcriptase (RT) and integrase activity (30, 37, 38) . Such L-2 particles were found to rapidly induce syncytia of MOLT-4 cells by virus-to-cell fusion, while wild-type LAI virus did not lead to syncytia formation under the same assay conditions (37) . Therefore, we predicted that L-2-like particles might be found among defective particles in late-stage asymptomatic HIV-1-infected patients and may play an important role in AIDS pathogenesis (29) . In this report, we have focused on the role of L-2 particles to induce apoptosis of a specific subset of U937-derived promonocytic cells.
Recently, it has been revealed that an effective induction of apoptosis occurs after cell-to-cell fusion between infected H9/III B and uninfected H9 cells, without the need for new viral replication (39) . We believe that the L-2 particle-induced apoptosis observed for specific low-but not high-type U937 subclones (low is defined as low susceptibility to HIV-1 infection) is analogous to this condition because it does not require infectious virus. Both low-and high-type subclones show similar levels of surface CD4, but differ in levels of lymphocyte function-associated antigen (LFA)-1, a marker for leukocyte maturation or activation (40) . This suggests the possible involvement of nuclear factors in the apoptotic event, since a similar pattern of differential apoptosis to that seen with L-2 particle preparations is induced by tumor necrosis factor (TNF)-a or anti-Fas antibody in both low-and high-type subclones of U937 cells. For example, there may be different levels of IL-ip-converting enzyme (ICE)-like nuclear enzymes in the two cell subsets.
Furthermore, the basal protein kinase C (PKC) activity in high-type subclones was significantly higher than low-type subclones. Since this kinase activity has been reported to enhance HIV-1 transcription via NF-KB activation (41) and inhibition of apoptosis (42, 43) , differential PKC activity among the four U937 subclones in this study might explain the different phenotypes observed.
Finally, we report rather surprisingly that wild-type LAI virus, in contrast to L-2 protease-defective particle preparations, did not significantly induce apoptosis in either the low-or high-type U937 subclone.
Methods

U937-derived subclones
U937 is a human promonocytic cell line that has been used extensively to study HIV-1 replication, and mechanisms underlying HIV-1-induced apoptosis, in monocytes (44) . We have recently isolated a total of 46 subclones from U937 cells, by limiting dilution in 96-well microplates (40) . Subclones were differentiated into three types (two high, 42 middle and two low) based on their HIV-1 replication kinetics, i.e. appearance of intracellular HIV-1 antigens and extracellular RT activity (40, 45) . Here, we have analyzed four representative subclones, two from high-type (#5H and #17H) and two from low-type (#15L and #26L) cells, as to their ability to be induced for apoptosis. Additionally, we used two representative subclones from middle-type (#12M and #22M) and parental U937 cells for some experiments. The U937 subclones, although expressing similar levels of surface CD4, appear to represent different states of maturation between monocytes and macrophages, as shown by the lower level of a LFA-1 expression in the high-type subclones compared with low-type subclones (40) .
Defective HIV-1 particle preparations
A defective HIV-1 particle-producing cell clone (L-2) was isolated from surviving M10 (MT-4 derived subclone) cells after HIV-1 wild-type LAI infection (46) . L-2 cells continuously produce doughnut-shaped particles which contain uncleaved Pr55 9a9 , and are negative for RT activity and infectivity (30, 37) . Recently, it was found that L-2 cell DNA had an insertional mutation at the 5' end of the protease gene, leading to formation of a stop codon (36) . Syncytia mediated by L-2 particles are formed after a 24 h incubation with MOLT-4 cells, but this does not occur with wild-type LAI particles; however, cell-to-cell fusion-mediated syncytia could be induced using either L-2 or LAI-infected cells (37) . The culture supernatants of L-2 cells were collected and used for the L-2 particle preparations, while culture supernatants of HIV-1 LAI-infected cells were used as controls.
Chemicals
TNF-oc and anti-Fas antibody were purchased from Upstate Biotechnology (Lake Placid, NY) and Medical Biological Laboratories (Nagoya, Japan) respectively. These chemicals were used in the experimental induction of apoptosis in the U937 subclones.
HIV-1 p24 antigen-capture ELISA
The amount of virus inocula was measured using an ELISA kit for Gag p24 antigen according to the manufacture's protocol (INTRACEL, Cambridge, MA). Both mature p24 and immature uncleaved Gag precursor p55 are detected by this kit.
Treatment of cells with TNF-cc, anti-Fas antibody or L-2 particle preparations
The high-and low-type subclones were treated with TNF-a or anti-Fas antibody in the presence of cycloheximide (CHX), as previously described (47) . Briefly, cells were cultured in TNF-a (150 U/ml) and CHX (0.4 jig/ml; Sigma, St Louis, MO) for 3 h, or in the presence of anti-Fas antibody (250 ng/ml) and CHX (0.4 ng/ml) for 5 h. In separate experiments, the subciones were treated with the culture supernatant of L-2 cells (L-2 particle preparations), which contained 5 ng (estimated by HIV-1 p24 antigen-capture ELISA kit) of L-2 particles, for 2 h at 37°C, then cultured at 37°C for 3 days in the absence or presence of CHX (0.4 ng/ml). As controls, cells were mock-treated or infected with wild-type LAI at the same particle concentration (estimated by HIV-1 p24 antigencapture ELISA).
Measurement of apoptosis
Apoptosis was measured by three methods. First, quantitative analysis of apoptosis was performed as previously described (14) , using propidium iodide staining of cells followed by flow cytometric analysis. Briefly, in this method, the cells were initially collected by centrifugation and the cell pellet was gently resuspended in a small amount of PBS, then fixed with cold 70% ethanol. After standing on ice for 30 min, cells were again centrifuged and the resultant cell pellet was resuspended in PBS containing RNase A (500 ng/ml) prior to incubation at 37°C for 20 min. After a final centrifugation, the cell pellet was resuspended in PBS containing propidium iodide (50 ng/ml) and incubated on ice for an additional 10 min. After staining, cells were resuspended in PBS, and analyzed using a FACScan system and the Cell Quest program (Becton Dickinson, Mountain View, CA). In the second approach, changes in cell morphology were visualized using a fluorescent microscope (11, 13) . Cells fixed with 4% paraformaldehyde in PBS for 2 h were treated with RNase A and stained with propidium iodide as above, prior to microscopic examination. In the third method, the degree of DNA fragmentation was determined by agarose gel electrophoresis using extracted cellular DNAs, as previously described (5, 45) . Cells collected after centrifugation were lysed in hypotonic buffer (10 mM Tris-HCI, pH 8.0, 5 mfvi EDTA and 0.5% Triton X-100), placed on ice for 30 min and centrifuged again. Then the supernatant containing low mol. wt DNA was deproteinized by extraction in phenol and chlorofomrisoamyl-alcohol (24:1), precipitated at -80°C in ethanol, 0.3 M sodium acetate for 15 min and centrifuged. Precipitates were dissolved in TE (10 mM Tris-HCI, pH 8.0, 1 mM EDTA) buffer, prior to electrophoreses on 1.0% agarose gels in TAE (40 mM Tris-HCI, pH 8.0, 40 mM acetic acid, 1 mM EDTA) buffer. DNA bands were visualized by ethidium bromide.
Binding rates of TNF-a, anti-Fas antibody and L-2 particles to the U937 subciones
For TNF-a, 1 x 10 6 cells of each U937 subclone were incubated with 125 l-labeled TNF-a (8.81 nCi/ng; DuPont NEN, Boston, MA) at 37°C for 30 min (48) . After washing, the radioactivity in both cell pellet and supernatant fractions was measured using a y-counter. The binding rate was determined by Scatchard plot analysis, while binding rates of anti-Fas antibody or L-2 particles (prepared by pelleting L-2 particle preparations at 70,000 r.p.m. for 30 min at 4°C) to cells were measured by flow cytometry. Specifically, for the latter cases, 1X10 6 cells of each subclone were incubated either with 20 |ig/ml of anti-Fas antibody or a control polyclonal mouse IgM at 4°C for 30 min, followed by a 1:40 dilution of FITCconjugated anti-mouse IgM (Dako, Glostrup, Denmark) at 4°C for 30 min and then analyzed by using a FACScan system and the Cell Quest program (Becton Dickinson). For the binding of L-2 particles, 5X10 5 cells of each subclone were incubated with 25 ng/100 |il (estimated by Gag p24 antigencapture ELISA) of L-2 particles at 37°C for 2 h. After washing, cells were stained with a 1:500 dilution of serum from an HIV-1-seropositive subject at 4°C for 30 min, followed by incubation with a 1:40 dilution of FITC-conjugated anti-human IgG (Dako) at 4°C for 30 min, prior to analysis by flow cytometry, as described above. As a control, a 1:500 dilution of HIV-1-seronegative human serum was used.
Indirect immunofluorescence
The kinetics of appearance of HIV-1 antigens in cells after infection with wild-type LAI was analyzed by indirect immunofluorescence, as described (49) . Cells were harvested every 3 days post-infection and glass slides of cell smears were prepared, then stained with sera from an HIV-1-seropositive subject.
Protein kinase assay
PKC and PKA activities were measured by using kits for these kinases (Protein Kinase C and A Assay Systems; Gibco/BRL, Gaithersburg, MD). Briefly, the subciones were adsorbed with wild-type LAI particle preparations for 2 h at 37 C C as described above, then cells were cultured for 0, 3, 6, 12, 24, 48 or 72 h at 37°C. At each time point, 1x10
6 cells of each subclone were collected and washed twice with cold PBS. Then cells were lysed in the extraction buffer supplied with the kits. The activity of each kinase in each cell lysate was measured according to the protocol described for the kits.
Results
Induction of apoptosis by defective L-2 particle preparations occurs more efficiently in low-rather than high-type subciones obtained from the U937 promonocytic cell line
We examined the induction of apoptosis by defective, protease-deficient HIV-1 (L-2) particle preparations on four U937 subciones. Analysis by flow cytometry, where the percentage of cells showing hypodiploid DNA was taken as an apoptotic index, showed that relative to mock treatment apoptosis occurred most efficiently (-30%) in the two low-type subclones, #15L and #26L ( Fig. 1A ; middle right top panels). Apoptosis by L-2 particle preparations was relatively inefficient (-5%) for the high-type U937 subciones, #5H and #17H ( Fig. 1 ; middle left top panels). Further we observed an enhancement of L-2-induced apoptosis for all subciones in the presence of CHX ( Fig. 1A ; middle bottom panels labeled L-2/CHX). Finally, it should be noted that wild-type LAI particle preparations did not induce a significant level of apoptosis in any of the four U937 subciones (1-4%), and this was only slightly enhanced (3-5%), when CHX was present ( Fig. 1A ; lower panels).
The effect of decreasing the L-2 particle concentration on apoptosis for two low-type versus high-type U937 subciones was then examined. It was found that even a 10-fold dilution of L-2 particles (0.5 ng/ml) still resulted in a -20% level of 2 . Kinetics of appearance of apoptosis for four U937-derived subclones after incubation with defective HIV-1 (L-2) particle preparations in the absence or presence of CHX. The two high-type (#5H, •; and #171-1,0) and two low-type (#15L, •; #26L, B) subclones were again adsorbed with 5 ng/ml (estimated by p24 antigen-capture ELISA) of the L-2 particle preparation for 2 h at 37°C, then cultured at 37°C for 2 days in the absence (A) or presence (B) of CHX (0.4 |ig/ml). As a control, cells were mock-treated. In this experiment, cells were harvested after 1 or 2 days and then analyzed by flow cytometry, as in Fig. 1 . The percentage of cells with hypodiploid DNA was quantified for each day.
apoptosis for the subclones, #15L and #26L, while there was no apoptosis for the subclones, #5H and #171-1, relative to mock-treated cells (data not shown). Further, the enhanced ability of CHX on inducing apoptosis within a shorter time period was observed for the low-type subclones (Fig. 1) . Analysis revealed that relative to no CHX addition ( Fig. 2A) , there was a significant induction of apoptosis by L-2 particle preparations at 1 day after CHX addition for the low-type subclones and by 2 days it was enhanced in one subclone (#15L) up to 60% (Fig. 2B) . Under the same conditions with CHX treatment, there was no ability to induce apoptosis at the 1 day point, using an equivalent amount of wild-type LAI particle preparation (data not shown).
In addition, we analyzed the ability of L-2 particle preparations to induce apoptosis in two representative middle-type subclones (#12M and #22M) as well as parental U937 cells. The results showed for CHX-treated L-2 preparations that an intermediate level (compared with high-and low-type subclones) of apoptosis was induced in both subclones. Figure 1(B) shows representative results for #22M and parental U937 cells. On average, 45, 25 and 10% apoptosis was observed respectively for low-, middle-(or parental) and high-type subclones.
Binding of L-2 particles to low-and high-type U937 subclones
In order to determine whether the enhanced apoptosis caused by L-2 particle preparations in U937 low-type relative to hightype subclones reflected an increased association of L-2 particle with low-type subclones, the level of particles bound to the four different subclones was assayed by flow cytometry. Serum from an HIV-1-seropositive subject was used to detect the presence of L-2 associated gp120 on the cells. No Relative fluorescence intensity Fig. 3 . Relative binding of L-2 particles to low-and high-type U937 subclones. A total of 5xio 5 cells in each subclone was similarly incubated with 25 ng/100 nl (estimated by p24 antigen-capture ELISA) of L-2 pelleted particles at 37°C for 2 h. After washing, cells were stained with serum from an HIV-1-seropositive patient (dark curve), followed by incubation with FITC-conjugated anti-human IgG and then analyzed by flow cytometry. As a control, a 1:500 dilution of HIV-1-seronegative human serum was used (open curve).
significant differences in the shift of fluorescence intensity were observed between low-versus high-type U937 cells (Fig. 3) . Binding of wild-type LAI particles to the same four U937 subclones did not exhibit any shift in fluorescence (data not shown).
Comparison between L-2 particle preparation-induced apoptosis of U937 subclones and apoptosis induced by TNF-cc or anti-Fas antibody
There was a higher percentage of apoptosis induced in lowtype subclones, #15L and #26L, after treatment with TNF-a and anti-Fas antibody, as compared to that seen with L-2 particle preparations (compare Fig. 4 , middle and lower right panels, with Fig. 1 , middle top right two panels). This probably reflects upon the point that the subclones treated with TNF-a (150 U/ml) or anti-Fas antibody (250 ng/ml) also had CHX (0.4 (ig/ml) added. Quantitative analysis of the percentage of cells with hypodiploid DNA after 3 h incubation with TNF-a or 5 h incubation with anti-Fas antibody revealed for TNF-a an induction of apoptosis in -70% of the two low-type subclones; while for anti-Fas antibody there was a -50% level of apoptosis. This contrasts with the 30% level seen for L-2 particle preparation-induced apoptosis of U937 low-type subclones (Fig. 1) . However, as noted, CHX was present throughout the TNF-a and anti-Fas antibody treatment, and it was shown earlier that apoptosis could be enhanced after CHX addition, up to a level of -60% (Fig. 1 , clone #15L with L-2/CHX; and Fig. 2B ).
Interestingly, we note in Fig. 4 (middle and lower left two panels) that the two high-type subclones (#5H and #17H) treated with TNF-a or anti-Fas antibody also induced a higher level of apoptosis above background, i.e. -11 or 21% with anti-Fas antibody or TNF-a respectively than that seen earlier, i.e. -5% with the L-2 particle preparations (Fig. 1) .
As an aside, we want to point out that it was necessary to use CHX in the experiments of Fig. 4 with TNF-a and antiFas antibody, in order to obtain a significant signal for measuring apoptosis. Without CHX, the signal was decreased 
5-fold for TNF-a and ~3.5-fold for anti-Fas antibody (data not shown).
Binding of TNF-a and anti-Fas antibody to the four U937 subclones
In order to determine if the increased apoptosis seen in Fig.  4 for TNF-a and anti-Fas antibody-treated low-type U937 subclones was attributable to enhanced binding, a Scatchard analysis was performed. Analysis of specific binding with 125 Ilabeled TNF-a revealed no significant correlation between apoptosis induction and binding efficiency of TNF-a to lowversus high-type U937 subclones (Fig. 5A) . Similarly, using flow cytometry, no significant correlation was observed between apoptosis induction and binding efficiency of antiFas antibody to the two types of U937 subclones (Fig. 5B) . Therefore, the difference regarding inducibility of apoptosis between high-and low-type subclones does not appear to be related to the binding efficiency of TNF-a or anti-Fas antibody to the cell surface, but is likely related to subsequent events, such as induction of intracellular signals involved in the induction of apoptosis.
Morphological comparison and DNA fragmentation analysis of the four U937 subclones after L-2 particle preparations, TNF-a and anti-Fas antibody induced apoptosis
Major morphological changes, including nuclear disintegration, were observed in the propidium iodide-labeled U937 low-type subclones after treatment with TNF-a for 3 h, antiFas antibody for 5 h or L-2 particle preparation for 2 days (Fig. 6) . The degradation observed was more severe after TNF-a or anti-Fas antibody treatment as compared with L-2 particle preparations exposure (Fig. 6, arrows) . Final confirmation by DNA fragmentation analysis, for the apoptosis induced in the low-versus high-type U937 subclones, after treatment with TNF-a, anti-Fas antibody or L-2 particle preparations, is shown in Fig. 7 . DNA was extracted from the appropriately treated U937 subclones and then analyzed by agarose gel electrophoresis. As expected, with the L-2 particle preparations, only the low-but not high-type subclones exhibited a clear banding pattern of fragmented DNA (multiples of -200 bp) characteristic of apoptosis (Fig. 7B) . Similarly, there was an enhanced degradation pattern seen in the low-type subclones after TNF-a or anti-Fas antibody treatment (Fig. 7A) .
Basal PKC activity was significantly higher in high-type subclones compared with low-type subclones
In order to clarify the intracellular signaling after adsorption with L-2 or HIV-1 (LAI) particle preparations, several different protein kinase assays were performed. First, the activities of PKC were measured for the four U937 subclones infected or uninfected with wild-type LAI at 3, 6, 12, 24, 48 and 72 h post-infection. The results show that basal PKC activity in high-type subclones was significantly higher than for low-type subclones (Fig. 8A) . In addition, gradually increased PKC activity was detected in all subclones after LAI infection (Fig.  8B) . Almost similar results were obtained for PKC activities after adsorption of L-2 particle preparation (data not shown). In contrast to PKC activity, no changes after adsorption of the L-2 and LAI particle preparation were observed for PKA activities in both types of subclones (data not shown).
Discussion
A large number of subclones was isolated from the U937 promonocytic cell line. They were categorized as to their relative permissiveness (high type) or non-permissiveness (low type), regarding the ability to replicate HIV-1 (40, 45) . The two low-type but not two high-type subclones could be apoptotically induced by L-2 protease-defective particle pre- 
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#17H #15L #26L Fig. 6 . Morphological change in cells of high-and low-type U937 subciones, observed after treatment with TNF-a, anti-Fas antibody or an L-2 particle preparation. Cells were treated as described in either Fig. 4 or Fig. 1 , fixed with 4% paraformaldehyde for 2 h, stained with propidium iodide and observed using a fluorescent microscope. Cells that appear to exhibit degradation products are denoted by arrows.
A #SH #17H #15L #26L I ! -: I i ? ! i r I n M i M i n Fig. 7 . DNA fragmentation patterns observed in U937 subclones after treatment with TNF-a, anti-Fas antibody or L-2 particle preparation. Two high-type (#5H and #17H) and two low-type (#15L and #26L) subclones were treated with TNF-a, anti-Fas antibody (A) or L-2 particle preparation (B) as described in either Fig. 4 or Fig. 1 , then lysed in hypotonic buffer. The supernatants were used to extract low mol. wt DNA. The DNA was deproteinized by extraction in phenol and chloroform:isoamyl-alcohol, precipitated at -80°C in ethanol and subjected to electrophoresis on a 1.0% agarose gels. DNA bands were visualized by staining with ethidium bromide.
parations ( Fig. 1) , as well as TNF-a and anti-Fas antibody (Fig. 4) . Middle-type subclones as well as parental U937 cells showed an intermediate sensitivity for apoptosis induced by these preparations (Fig. 1B) , as compared to high-and lowtype subclones. For high-and low-type subclones, there were no significant differences in the initial binding rates of L-2 particles (Fig. 3) as well as the binding of TNF-a or antiFas antibody (Fig. 5) to the subclones. Since the low-type subclones expressed higher levels of LFA-1 on the cell surface than the high-type subclones (40) , they may be more advanced in differentiation along the monocytic pathway. Further, the basal PKC activity was significantly higher in high-type subclones as compared with low-type subclones (Fig. 8) . Recently, PKC activity was assessed for its inhibitory effect on apoptosis (42, 43) . These reports suggest that the low levels of basal PKC activity, as noted in low-type subclones, might reflect their increased sensitivity to L-2 particle preparation-induced apoptosis. Although activation of Bcl-2 was reported to exist down-stream to PKC signaling (50), preliminary results (by immunoblotting) show that expression of the Bcl-2 product is at a similar level for both low-and high-types of subclones (data not shown). Also, it was recently shown that poly(ADP-ribose) polymerase (PARP) activity in the two low-type subclones was significantly higher than in the two high-type subclones (51) . We found that this likely results from higher levels of PARP-degrading protease activity in the high-type subclones. Thus, inducibility of this novel PARP-degrading serine protease to a higher level can occur in the low-type subclones. Studies on the enzyme are in progress and it appears to be different than the NF-KBhydrolyzing protease found by Franzoso et al. (52) or ICElike PARP-degrading protease (53) .
The mechanism by which apoptosis is induced in the lowtype subclones may also be different for treatment with TNF-a and anti-Fas antibody, as compared to L-2, protease-defective particle preparations (Figs 6 and 7) , even though addition of CHX significantly amplified apoptosis in all three cases ( Figs  1 and 4) . The enhancement by CHX itself may reflect inhibition in the translation of a serine protease inhibitor which normally blocks the protease involved in apoptosis induction (54) (55) (56) (57) . However, the slower induction of apoptosis after treatment with L-2 particle preparations (Fig. 2) suggests instead a mechanism similar to that proposed for IL-6-mediated apoptosis, which also shows a slower kinetics (1-3 days after treatment) of apoptosis in U937 cells (58) .
The mechanisms involved in L-2 particle preparationmediated apoptosis are not fully clear, i.e. we could not detect Downloaded from https://academic.oup.com/intimm/article-abstract/8/11/1687/707271 by guest on 09 April 2019 a significant level of apoptosis when using L-2 particles which were precipitated by using ultracentrifugation, while L-2 particle preparations (culture supernatant of L-2 cells) could induce apoptosis. This might be due to the occurrence of phenotypic changes in L-2 particles upon ultracentrifugation. In addition, the mechanism by which L-2 particle preparations induced apoptosis seems to be different from that seen with TNF-oc or anti-Fas antibody. Our preliminary studies revealed that secretion of TNF-a, enhanced expression of Fas antigen or expression of Fas ligand were not detected in the four U937 subclones after adsorption with L-2 particle preparations (data not shown). Furthermore, anti-TNF-a neutralizing antibody or Fas antagonist could not block the L-2 particle preparation-mediated apoptosis (data not shown).
In contrast to the ability of L-2 particle preparations, wildtype LAI virus preparations did • not significantly induce apoptosis in either low-or high-type U937 subclones (Fig. 1 ). This may reflect upon different degrees of the amount of gp120, stability and/or conformation on the surface of L-2 versus wild-type virus particles. In fact, an immunoblot analysis of HIV-1 structural proteins showed a significantly higher amount of Env gp120 in L-2 particles than wild-type LAI particles (data not shown). Further, sequence analysis of L-2 proviral DNA revealed mutations in env, vpr and nef (data not shown), in addition to one-base insertion in po/(36). However, mutation(s) needed in L-2 to induce higher levels of apoptosis are not clear at present.
Based on these ideas we propose that in HIV-1-infected patients, there are potentially two different groups of CD4 + cells among the PBMC, i.e. ones with a high and others with a low susceptibility to HIV-1 infection. The former group would provide a reservoir for productive infection of virus, while the latter group of HIV-1 genome-negative cells would remain sensitive to apoptotic cell lysis. This hypothesis is consistent with recent in vivo results that apoptosis occurs predominantly in bystander viral genome-negative cells and not in the productively infected cells themselves (22) . Thus, the twotypes of subclones we have derived from the U937 cell line could serve in lieu of trying to isolate similar populations of CD4 + cells as a model cell system to test whether AIDS pathogenesis is indeed regulated by two such functionally different CD4 + cell populations.
